12/20/2024
12:19 PM | Abrdn Life Sciences Investors (Issuer)
Wilson Ashton (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2024
12:20 PM | Abrdn Life Sciences Investors (Issuer)
Silue Kolotioloma (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
10:48 AM | Abrdn Life Sciences Investors (Filer)
| Form N-CEN
Annual Report for Registered Investment Companies | |
12/09/2024
12:05 PM | Abrdn Life Sciences Investors (Filer)
| Form N-CSR
Certified shareholder report of registered management investment companies | |
11/27/2024
9:59 AM | Abrdn Life Sciences Investors (Filer)
| Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT | |
08/28/2024
1:07 PM | Abrdn Life Sciences Investors (Filer)
| Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT | |
08/27/2024
1:46 PM | Abrdn Life Sciences Investors (Issuer)
Maher Bill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/15/2024
9:46 AM | ABRDN ASIA-PACIFIC INCOME FUND, INC. (Filer)
ABRDN AUSTRALIA EQUITY FUND, INC. (Filer)
ABRDN EMERGING MARKETS EQUITY INCOME FUND, INC. (Filer)
abrdn Funds (Filer)
abrdn Global Dynamic Dividend Fund (Filer)
ABRDN GLOBAL INCOME FUND, INC. (Filer)
abrdn Global Infrastructure Income Fund (Filer)
abrdn Global Premier Properties Fund (Filer)
abrdn Healthcare Investors (Filer)
abrdn Healthcare Opportunities Fund (Filer)
abrdn Income Credit Strategies Fund (Filer)
ABRDN JAPAN EQUITY FUND, INC. (Filer)
Abrdn Life Sciences Investors (Filer)
abrdn National Municipal Income Fund (Filer)
abrdn Total Dynamic Dividend Fund (Filer)
abrdn World Healthcare Fund (Filer)
| Form 40-17G | |
07/18/2024
1:56 PM | Abrdn Life Sciences Investors (Issuer)
DiMartino Rose (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
10:22 AM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:36 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
2:18 PM | Abrdn Life Sciences Investors (Issuer)
Nichols Rebecca Suzanne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2024
2:28 PM | Abrdn Life Sciences Investors (Issuer)
Taggart Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/14/2024
12:59 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
1:34 PM | Abrdn Life Sciences Investors (Filer)
| Form N-CSRS | |
06/10/2024
7:45 AM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:09 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:11 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
8:15 AM | Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
05/31/2024
2:08 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
8:13 AM | Abrdn Life Sciences Investors (Filer)
| Form DEFA14A | |
05/23/2024
6:41 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
11:34 AM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
12:50 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
9:31 AM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:50 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
9:52 AM | Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
04/26/2024
10:40 AM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
7:00 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:12 PM | Abrdn Life Sciences Investors (Filer)
| Form DEF 14A | |
04/22/2024
2:08 PM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
7:05 AM | Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2024
7:32 AM | Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
04/12/2024
8:20 AM | Abrdn Life Sciences Investors (Issuer)
Goetz Kathleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
11:38 AM | Abrdn Life Sciences Investors (Issuer)
Tse Loretta (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/29/2024
11:37 AM | Abrdn Life Sciences Investors (Filer)
| Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT | |
02/07/2024
6:55 AM | Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
01/12/2024
10:41 AM | Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
01/04/2024
1:23 PM | Abrdn Life Sciences Investors (Issuer)
Reit Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:34 PM | Abrdn Life Sciences Investors (Issuer)
Maher Bill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
6:54 AM | Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13D | |
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
12/22/2023
1:12 PM | Abrdn Life Sciences Investors (Issuer)
Ritchie Ben (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2023
1:15 PM | Abrdn Life Sciences Investors (Issuer)
Duitz Joshua (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
